Ana L. Negro-Pelayo

Queen Square
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Longitudinal analysis shows GAA1 length and baseline clinical status as robust predictors of progression in Friedreich ataxia.

Longitudinal analysis shows GAA1 length and baseline clinical status as robust predictors of progression in Friedreich ataxia.

Journal: Journal of neurology

Published: December 17, 2025

Progression of biological markers in spinocerebellar ataxia type 3: longitudinal analysis of prospective data from the ESMI cohort.

Progression of biological markers in spinocerebellar ataxia type 3: longitudinal analysis of prospective data from the ESMI cohort.

Journal: The Lancet regional health. Europe

Published: February 01, 2025

Isolated CSF RT-QuIC positivity associates with a less aggressive disease course and decreased levels of neuronal/glial damage biomarkers in patients with sporadic Creutzfeldt-Jakob disease.

Isolated CSF RT-QuIC positivity associates with a less aggressive disease course and decreased levels of neuronal/glial damage biomarkers in patients with sporadic Creutzfeldt-Jakob disease.

Journal: Journal of neurology

Published: September 19, 2024

Expanding the Clinical Spectrum of DRP2-Associated Charcot-Marie-Tooth Disease.

Expanding the Clinical Spectrum of DRP2-Associated Charcot-Marie-Tooth Disease.

Journal: Neurology

Published: March 21, 2024

Alternative splicing expands the clinical spectrum of NDUFS6-related mitochondrial disorders.

Alternative splicing expands the clinical spectrum of NDUFS6-related mitochondrial disorders.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: October 17, 2023

Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.

Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.

Journal: Neurologia

Published: September 12, 2023

Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review.

Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review.

Journal: European journal of internal medicine

Published: January 20, 2022

Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome.

Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome.

Journal: Annals of clinical and translational neurology

Published: October 22, 2021

Ataxia and Action Myoclonus Related to Novel Mutations in ATP13A2 Gene.

Ataxia and Action Myoclonus Related to Novel Mutations in ATP13A2 Gene.

Journal: Movement disorders clinical practice

Published: March 23, 2021

Clinical characteristics and outcomes of thymoma-associated myasthenia gravis.

Clinical characteristics and outcomes of thymoma-associated myasthenia gravis.

Journal: European journal of neurology

Published: February 07, 2021

Antibodies against nodo-paranodal proteins are not present in genetic neuropathies.

Antibodies against nodo-paranodal proteins are not present in genetic neuropathies.

Journal: Neurology

Published: October 01, 2019

Very early Guillain-Barré syndrome: A clinical-electrophysiological and ultrasonographic study.

Very early Guillain-Barré syndrome: A clinical-electrophysiological and ultrasonographic study.

Journal: Clinical neurophysiology practice

Published: September 04, 2019

Showing 1-12 of 39

Last Updated: 09/26/2026